Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Tamara Pang"'
Autor:
Tamara Pang, Alakananda Gudi
Publikováno v:
Proceedings of Singapore Healthcare, Vol 28 (2019)
Selective serotonin reuptake inhibitors are considered to be the drug of choice in patients with major depression and cardiovascular disease. Fluvoxamine in particular has been shown to be safe for use in patients with cardiovascular disease. We repo
Externí odkaz:
https://doaj.org/article/319d3a29b8ca458ca9652c25b85897dc
Periodic psychosis in relation to the menstrual cycle phases has been reported but its pathogenesis not yet known. We report a case of a 28 year old female with schizoaffective disorder since 18 years old. She was diagnosed with polycystic ovary synd
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::978006bb15d766f178b29a8b402faf4d
https://doi.org/10.21203/rs.3.rs-38120/v1
https://doi.org/10.21203/rs.3.rs-38120/v1
Autor:
Tamara Pang, Alakananda Gudi
Publikováno v:
Proceedings of Singapore Healthcare, Vol 28 (2019)
Selective serotonin reuptake inhibitors are considered to be the drug of choice in patients with major depression and cardiovascular disease. Fluvoxamine in particular has been shown to be safe for use in patients with cardiovascular disease. We repo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::469e9802788050e27071be1b1ff387e9
https://doi.org/10.1177/2010105818802993
https://doi.org/10.1177/2010105818802993
Autor:
Lee Boo Tan, Janet Chong, Yu Tien Wang, Ennaliza Salazar, Khoon-Lin Ling, Kia Lan Loy, Ho Man Ng, Tamara Pang, Palash Ghosh, Hui Lin Beh, Bee Yen Poh, Victor Tan
Publikováno v:
Clinical nutrition ESPEN. 33
Summary Introduction Most studies on alternative intravenous lipid emulsion (IVLE) versus conventional IVLE have been conducted in the critically ill patients. The benefits of alternative IVLE in non-critically ill patients is uncertain. We aim to de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c9898c44b8870e341b7d4e9c2f0e4b2
https://pubmed.ncbi.nlm.nih.gov/31451274
https://pubmed.ncbi.nlm.nih.gov/31451274
Publikováno v:
Journal of Gastroenterology and Hepatology. 30:866-871
Background and Aim Adult patients with cystic fibrosis (CF) have an increased risk of gastrointestinal malignancies. We hypothesized that increased intestinal cell turnover beginning in childhood may explain the increased risk of malignancy in early
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::acb6a3dd5bfdcc72dba9ae9471642a65
https://doi.org/10.1111/jgh.12842
https://doi.org/10.1111/jgh.12842
Autor:
Adam Jaffe, Roxanne Strachan, Lily Nahidi, Steven T. Leach, Chee Y. Ooi, Jung M. Lee, Jasbir Dhaliwal, Tamara Pang, Tamarah Katz, Andrew S. Day
Publikováno v:
Journal of Pediatric Gastroenterology & Nutrition. 60:521-526
Objective: The aim of the study was to evaluate and compare faecal markers of intestinal inflammation in children with cystic fibrosis (CF), and determine whether intestinal inflammation adversely affects the nutritional phenotype. Methods: Faecal sa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33b6442e93b020a181e6a254af47bde7
https://doi.org/10.1097/mpg.0000000000000683
https://doi.org/10.1097/mpg.0000000000000683
Autor:
Tamarah Katz, Michael J. Coffey, Millie Garg, Roxanne Strachan, Adam Jaffe, Sandra Chuang, Yvonne Belessis, Penelope Field, Andrew S. Day, Chee Y. Ooi, John Widger, Steven T. Leach, Bronwen Needham, Tamara Pang
Publikováno v:
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society. 17(1)
Background The pathogenesis of gut inflammation, bacterial dysbiosis and increased rates of malignancy in CF is unclear. Fecal M2-pyruvate kinase (M2-PK) is a biomarker indicative of cellular proliferation that may be raised in intestinal malignancy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ea5d6489ef97843827e3a287717252f
https://pubmed.ncbi.nlm.nih.gov/28754328
https://pubmed.ncbi.nlm.nih.gov/28754328
Autor:
Millie Garg, Tamara Pang, Tamarah Katz, Bronwen Needham, Vesal Moeeni, Laura Appleton, Kei Lui, Adam Jaffe, Roxanne Strachan, Michael J. Coffey, Chee Y. Ooi, Fathalla Ali, Steven T. Leach, Andrew S. Day
Publikováno v:
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society. 16(5)
Background Fecal calprotectin may be used as a non-invasive method to assess the effect of novel therapies on the gut in cystic fibrosis (CF). Method Stools from CF patients and healthy controls (HC) (0–10years old) were prospectively collected for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ee8cfb44d4cd45a1b77c2717a6af680
https://pubmed.ncbi.nlm.nih.gov/29128316
https://pubmed.ncbi.nlm.nih.gov/29128316
Publikováno v:
Digestive diseases and sciences. 60(10)
Defects in bacterial host defenses in the cystic fibrosis (CF) airways have been extensively investigated, but the role of the intestinal innate immune system in CF is unknown. Human β-defensin 2 (HBD-2) is an antimicrobial protein produced by epith
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1395c347dcfda2b1b18e7a44619d5bf
https://pubmed.ncbi.nlm.nih.gov/26271615
https://pubmed.ncbi.nlm.nih.gov/26271615
Publikováno v:
Journal of gastroenterology and hepatology. 30(5)
Adult patients with cystic fibrosis (CF) have an increased risk of gastrointestinal malignancies. We hypothesized that increased intestinal cell turnover beginning in childhood may explain the increased risk of malignancy in early adulthood. Therefor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b1cf19decbce8ffe3ec4322a9a92a73a
https://pubmed.ncbi.nlm.nih.gov/25376228
https://pubmed.ncbi.nlm.nih.gov/25376228